If an entity was interested in funding INDs which require a substantial investment (15 mil+), one way to mitigate risk or hedge would be to acquire a large stake in the parent company before funding a spinoff. Immediately they could reduce capital exposure while participating in both facets of potentially lucrative stem cell technology..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.